Stock comparison
Lumexa Imaging Holdings
LMRI$1.11BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.05BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
LMRI 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
LMRI0wins
7winsSANOFICONR.BO
28F
B78
28F
A89
17F
B83
23F
B77
40F
A91
20F
A86
15F
A85
Side-by-side metrics
| Metric | LMRI | SANOFICONR.BO |
|---|---|---|
| Market cap | $1.11B | $104.05B Winner |
| P/E (TTM) | Winner: - | 44.0x |
| EV/EBIT | 62.2x | 31.7x Winner |
| ROIC (TTM) | 0.75% | 59.15% Winner |
| Gross margin | 9.91% | 68.13% Winner |
| Net margin | -6.77% | 27.35% Winner |
| Revenue CAGR 5y | 4.55% | 27.01% Winner |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | 1.6x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMRI leads on
- P/E (TTM)-vs 44.0x+133%
SANOFICONR.BO leads on
- Net margin27.35%vs -6.77%+125%
- Market cap$104.05Bvs $1.11B+99%
- ROIC (TTM)59.15%vs 0.75%+99%
- Debt / Equity0.1xvs 1.6x+96%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.